The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Effects of Long-term Vitamin E Supplementation on Cardiovascular Events and Cancer: A Randomized Controlled Trial
Open accessAbstract
CONTEXT: Experimental and epidemiological data suggest that vitamin E supplementation may prevent cancer and cardiovascular events. Clinical trials have generally failed to confirm benefits, possibly due to their relatively short duration. OBJECTIVE: To evaluate whether long-term supplementation with vitamin E decreases the risk of cancer, cancer death, and major cardiovascular events. DESIGN, SETTING, AND PATIENTS: A randomized, double-blind, placebo-controlled international trial (the initial Heart Outcomes Prevention Evaluation [HOPE] trial conducted between December 21, 1993, and April 15, 1999) of patients at least 55 years old with vascular disease or diabetes mellitus was extended (HOPE-The Ongoing Outcomes [HOPE-TOO]) between April 16, 1999, and May 26, 2003. Of the initial 267 HOPE centers that had enrolled 9541 patients, 174 centers participated in the HOPE-TOO trial. Of 7030 patients enrolled at these centers, 916 were deceased at the beginning of the extension, 1382 refused participation, 3994 continued to take the study intervention, and 738 agreed to passive follow-up. Median duration of follow-up was 7.0 years. INTERVENTION: Daily dose of natural source vitamin E (400 IU) or matching placebo. MAIN OUTCOME MEASURES: Primary outcomes included cancer incidence, cancer deaths, and major cardiovascular events (myocardial infarction, stroke, and cardiovascular death). Secondary outcomes included heart failure, unstable angina, and revascularizations. RESULTS: Among all HOPE patients, there were no significant differences in the primary analysis: for cancer incidence, there were 552 patients (11.6%) in the vitamin E group vs 586 (12.3%) in the placebo group (relative risk [RR], 0.94; 95% confidence interval [CI], 0.84-1.06; P = .30); for cancer deaths, 156 (3.3%) vs 178 (3.7%), respectively (RR, 0.88; 95% CI, 0.71-1.09; P = .24); and for major cardiovascular events, 1022 (21.5%) vs 985 (20.6%), respectively (RR, 1.04; 95% CI, 0.96-1.14; P = .34). Patients in the vitamin E group had a higher risk of heart failure (RR, 1.13; 95% CI, 1.01-1.26; P = .03) and hospitalization for heart failure (RR, 1.21; 95% CI, 1.00-1.47; P = .045). Similarly, among patients enrolled at the centers participating in the HOPE-TOO trial, there were no differences in cancer incidence, cancer deaths, and major cardiovascular events, but higher rates of heart failure and hospitalizations for heart failure. CONCLUSION: In patients with vascular disease or diabetes mellitus, long-term vitamin E supplementation does not prevent cancer or major cardiovascular events and may increase the risk for heart failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, despite this, vitamin E did not improve cardiovascular outcomes in a large multicenter trial and actually increased congestive heart failure (201).”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [201]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Part of this paper’s reference list could not be split into single entries.
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341802 · Cited by 3,638
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Miller, E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00110 · Cited by 2,577
Brown, B. G., Zhao, X.-Q., Chait, A., Fisher, L. D., Cheung, M. C., Morse, J. S., Dowdy, A. A., Marino, E. K., Bolson, E. L., Alaupovic, P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011090 · Cited by 1,979
Vivekananthan, D. P., Penn, M. S., Sapp, S. K., Hsu, A., & Topol, E. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13637-9 · Cited by 1,083
Bjelaković, G., Nikolova, D., Simonetti, R. G., & Gluud, C. N. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17138-9 · Cited by 619
Vitamin E in Humans: Demand and Delivery
Traber, M. G., & Sies, H. (1996) · Annual Review of Nutrition · doi:10.1146/annurev.nu.16.070196.001541 · Cited by 502
Jha, P., Flather, M., Lonn, E., Farkouh, M., & Yusuf, S. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-11-199512010-00009 · Cited by 399
SERUM VITAMIN E AND RISK OF CANCER AMONG FINNISH MEN DURING A 10-YEAR FOLLOW-UP
Knekt, P., Aromaa, A., Maatela, J., Aaran, R., Nikkari, T., Hakama, M., Hakulinen, T. R., Peto, R., Saxén, E., & Teppo, L. (1988) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114788 · Cited by 233
Clinical trials of antioxidants in atherosclerosis: are we doing the right thing?
Steinberg, D. H. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92657-7 · Cited by 178
Huang, H.-Y. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwf210 · Cited by 173
Research works printed but not linked: 18
- Verlangieri AJ, Bush MJ. Effects of d-␣-tocopherol supplementation on experimentally induced primate atherosclerosis. J Am Coll Nutr. 1992;11:131-138.
- Meydani M. Vitamin E. Lancet. 1995;345:170-175.
- Skyrme-Jones RA, O'Brien RC, Berry KL, Meredith IT. Vitamin E supplementation improves endothelial function in type 1 diabetes mellitus: a randomized, pla- cebo-controlled study. J Am Coll Cardiol. 2000;36:94- 100.
- Sigounas G, Anagnostou A, Steiner M. dl-alpha- Tocopherol induces apoptosis in erythroleukemia, pros- tate, and breast cancer cells. Nutr Cancer. 1997;28:30- 35.
- Ziegler RG, Mayne ST, Swanson CA. Nutrition and lung cancer [review]. Cancer Causes Control. 1996;7:157- 177.
- Longnecker MP, Martin-Moreno JM, Knekt P, et al. Serum alpha-tocopherol concentration in relation to sub- sequent colo-rectal cancer: pooled data from five cohorts. J Natl Cancer Inst. 1992;84:430-445.
- Ocke MC, Bueno-de-Mesquita HB, Feskens EJ, van Staveren WA, Kromhout D. Repeated measurements of vegetables, fruits, beta-carotene, and vitamins C and E in relation to lung cancer: the Zutphen Study. Am J Epidemiol. 1997;145:358-365.
- Klein EA, Thompson IM, Lippman SM, et al. SELECT: the next prostate cancer prevention trial: Selenium and Vitamin E Cancer Prevention Trial. J Urol. 2001;166:1311- 1315.
- Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with ␣-tocopherol and -carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst. 1998;90:440-446.
- Li J-Y, Taylor PR, Li B, et al. Nutrition intervention trials in China: multiple incidence and disease-specific mor- tality among adults with esophageal dysplasia. J Natl Can- cer Inst. 1993;85:1492-1498.
- The Alpha-Tocopherol, Beta Carotene Cancer Pre- vention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other can- cers in male smokers. N Engl J Med. 1994;330: 1029-1035.
- Steinberg D, Witzum JL. Is the oxidative modifi- cation hypothesis relevant to human atherosclerosis: do the antioxidant trials conducted to date refute the hypothesis? Circulation. 2002;105:2107-2111.
- The Heart Outcomes Prevention Evaluation Study Investigators. Vitamin E supplementation and cardio- vascular events in high-risk patients. N Engl J Med. 2000;342:154-160.
- Lonn E, Shaikholeslami R, Yi Q, et al. Effects of ramipril on left ventricular mass and function in car- diovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a sub- study of the HOPE trial. J Am Coll Cardiol. 2004;43: 2200-2206.
- GISSI-Prevenzione Investigators (Gruppo Itali- ano per lo Studio della Sopravvivenza nell'Infracto Miocardico). Dietary supplementation with n-e poly- unsaturated fatty acids and vitamin E after myocar- dial infarction: results of the GISSI-Prevenzione Trial. Lancet. 1999;354:447-455.
- Age-Related Eye Disease Study Group. A ran- domized, placebo-controlled, clinical trial of high-dose supplementation with vitamin C and E and beta-carotene for age-related cataract and vi- sion loss: AREDS Report No. 9. Arch Ophthalmol. 2001; 119:1439-1452.
- Collaborative Group of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet. 2001;342:154-160.
- Bowry VW, Ingold KU, Stocker R. Vitamin E in human low-density lipoproteins: when and how this antioxidant becomes a pro-oxidant. Biochem J. 1992; 288:341-344.
Cited by
Sorted by citations
Items 601–700 of 999
The vitamin E debate: implications for ongoing trials of pre‐eclampsia prevention
Fraser, W. D., Audibert, F., Bujold, E., Leduc, L., Xu, H., Boulvain, M., & Julien, P. (2005) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2005.00675.x · Cited by 25
“A recent publication that reports on an extension of follow up in the HOPE trial patients found no evidence of an increase in mortality among study participants.(20) However, the study did observe an increase in heart failure among patients exposed with prolonged exposure.”
BackgroundKumar, R., Deep, G., Wempe, M. F., Surek, J., Kumar, A., Agarwal, R., & Agarwal, C. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22731 · Cited by 24
Li, Y., Wang, Y., Chen, Y., Wang, Y., Zhang, S., Liu, P., Chen, Z., Song, P., Luo, L., Luo, Y., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01611 · Cited by 24
“Unfortunately, attempts to counteract coronary heart disease by preventing activation of the innate immune system by antioxidants (43) or selective inhibitors of Lp-PLA2 (44, 45) have failed.”
BackgroundZhi, F., Zhang, Q., Liu, L., Chang, X., & Xu, H. (2023) · Cell Stress and Chaperones · doi:10.1007/s12192-023-01361-w · Cited by 24
Veettil, S. K., Jinatongthai, P., Nathisuwan, S., Teerawattanapong, N., Ching, S. M., Lim, K. G., Saokaew, S., Phisalprapa, P., Reid, C. M., & Chaiyakunapruk, N. (2018) · Clinical Epidemiology · doi:10.2147/clep.s174120 · Cited by 24
“VI.MAX Yes, parallel General population 13,017 49 39 AOs; PLB 7.5 7.5 CV events, cancers and overall mortality Lonn et al (2005)/ Lonn et al (2006)11,12 HOPEa Yes, 2×2 factorial History of CV diseases or diabetes 9,541 66 73 AOs; FA+B6+B12; PLB 4.5 4.5 Cancer incidence, cancer deaths, major CV…”
BackgroundInfluentialNain, S., Wojnarowicz, C., Laarveld, B., & Olkowski, A. A. (2008) · British Poultry Science · doi:10.1080/00071660802415658 · Cited by 24
“Our findings are consistent with those reported in the human literature, where vitamin E supplementation either had no beneficial effect or in some cases increased the risk of heart failure (Liu and Tan, 2002; Lonn et al., 2005; Miller et al., 2005; Shelton et al., 2005).”
BackgroundResultAntioxidant treatment for heart failure: friend or foe?
Thomson, M. J., Frenneaux, M. P., & Kaski, J. C. (2008) · QJM · doi:10.1093/qjmed/hcn160 · Cited by 24
Cardiac Response to Oxidative Stress Induced by Mitochondrial Dysfunction
Kim, H. K., Nilius, B., Kim, N., Ko, K. S., Rhee, B. D., & Han, J. (2016) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2015_5004 · Cited by 26
Pervin, M., & de Haan, J. B. (2025) · Antioxidants · doi:10.3390/antiox14111278 · Cited by 28
The Two Sides of Vitamin E Supplementation
Ochi, H., & Takeda, S. (2014) · Gerontology · doi:10.1159/000366419 · Cited by 23
Cheng, P., Chen, W., Hou, C. J., Lin, C., Chang, M., Wang, C., Chang, W., Wang, C., Lin, C., Hung, C., et al. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2023.0315 · Cited by 25
Fat‐Soluble Vitamins in Advanced CKD/ESKD: A Review
Holden, R. M., Ki, V., Morton, A. R., & Clase, C. M. (2012) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2012.01084.x · Cited by 23
Chang, Y. J., Myung, S., Chung, S. T., Kim, Y., Lee, E., Jeon, Y.-J., Park, C.-H., Seo, H. G., & Huh, B. Y. (2011) · Dermatology · doi:10.1159/000329439 · Cited by 24
Nutritional Recommendations for Patients With Heart Failure
Lennie, T. A. (2006) · The Journal of Cardiovascular Nursing · doi:10.1097/00005082-200607000-00005 · Cited by 23
“a large randomized trial, long-term natural-source vitamin E supplementation of 400 IU/d demonstrated no benefit for the prevention of myocardial infarction, angina, stroke, or cardiovascular death.(21)”
BackgroundThe Role of Glucosamine-Induced ER Stress in Diabetic Atherogenesis
Beriault, D. R., & Werstuck, G. H. (2012) · Experimental Diabetes Research · doi:10.1155/2012/187018 · Cited by 21
“While preclinical evidence supports a causative role for oxidative stress in atherogenesis [38–41], virtually every wellcontrolled clinical trial has failed to show a cardiovascular benefit in diabetic patients receiving antioxidant supplements [42–46].”
BackgroundDaryani, A., Basu, S., Becker, W., Larsson, A. O., & Risérus, U. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.07.011 · Cited by 23
Selenium and Vitamin E for Prostate Cancer - Justifications for the SELECT Study
Ramamoorthy, V., Rubens, M., Saxena, A., & Shehadeh, N. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.7.2619 · Cited by 23
“…et al., 1999; Group, 2002; Schuurman et al., 2002; Duffield-Lillico et al., 2003; Virtamo et al., 2003; Hodge et al., 2004; Rodriguez et al., 2004; Lonn et al., 2005; McCann et al., 2005; Meyer et al., 2005; Kirsh et al., 2006; Weinstein et al., 2007; Wright et al., 2007; Bidoli et al., 2009;…”
BackgroundVitamin E reduces liver stiffness in nonalcoholic fatty liver disease
Fukui, A. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i27.2749 · Cited by 23
Vitamin supplements in type 2 diabetes mellitus management: A review
Yan, M. K., & Khalil, H. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.04.009 · Cited by 24
“conducted a randomised, double-blind, placebocontrolled trial investigating the effects of a daily dose of vitamin E (400 IU) in subjects with either vascular disease or diabetes mellitus [29].”
BackgroundLevy, A. P., & Blum, S. (2007) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.5.6.1105 · Cited by 23
Yang, X., Zhao, N., Liu, Y., Hu, B., Sun, K., Chang, X., Wei, X., Fan, J., & Han, J. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/728020 · Cited by 23
Nadeem, N., Woodside, J. V., Kelly, S. M., Allister, R., Young, I. S., & McEneny, J. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.04.009 · Cited by 23
Vitamin intake and risk of coronary disease: Observation versus intervention
Moats, C., & Rimm, E. B. (2007) · Current Atherosclerosis Reports · doi:10.1007/s11883-007-0068-6 · Cited by 24
The protective effect of hydrogen-rich water on rats with type 2 diabetes mellitus
Zheng, M., Yu, H., Xue, Y., Yang, T., Tu, Q., Xiong, K., Deng, D., Lu, L., & Huang, N. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04145-x · Cited by 22
The Problem with Nutritionally Enhanced Plants
Schubert, D. R. (2008) · Journal of Medicinal Food · doi:10.1089/jmf.2008.0094 · Cited by 22
“For example, a clinical trial with vitamin E supplementation showed that a relatively small dose increased the risk of heart failure, 48 and smokers who supplemented their diet with (cid:2) -carotene had an increased risk of lung cancer.”
Diet and prostate cancer risk reduction
Cheung, E. M., Wadhera, P., Dorff, T. B., & Pinski, J. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.1.43 · Cited by 22
A Review of Non-Hormonal Options for the Relief of Menopausal Symptoms
Albertazzi, P. (2006) · Treatments in Endocrinology · doi:10.2165/00024677-200605020-00004 · Cited by 22
Recommendations for nutritional supplements for dry eye disease: current advances
Cong, Y., Zhang, Y., Han, Y., Wu, Y., Wang, D., & Zhang, B. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1388787 · Cited by 22
Martinez, C. S., Zheng, A., & Xiao, Q. (2024) · Antioxidants · doi:10.3390/antiox13111330 · Cited by 26
Rocchini, A. P., Hayman, L. L., Daniels, S. R., McCrindle, B. W., Urbina, E. M., Dennison, B. A., & Jacobson, M. Z. (2007) · Cited by 21
Emerging Therapy for Diabetic Cardiomyopathy: From Molecular Mechanism to Clinical Practice
Hsuan, C., Teng, S. I. F., Hsu, C., Liao, D., Chang, A. J.-W., Lee, H.-L., Hee, S., Chang, Y., & Chuang, L. (2023) · Biomedicines · doi:10.3390/biomedicines11030662 · Cited by 23
Exercise-induced oxidative stress: A tool for “hormesis” and “adaptive response”
Koyama, K. (2014) · The Journal of Physical Fitness and Sports Medicine · doi:10.7600/jpfsm.3.115 · Cited by 23
Muid, S. A., Froemming, G. R. A., Rahman, T. H. A., Ali, A. M., & Nawawi, H. M. (2016) · Food & Nutrition Research · doi:10.3402/fnr.v60.31526 · Cited by 21
Nzuza, S., Ndwandwe, D. E., & Owira, P. M. O. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.07.041 · Cited by 21
Emiru, Y. K., Belay, Y. B., Bizuneh, G. K., & Tegegn, H. G. (2019) · Nutrition and Dietary Supplements · doi:10.2147/nds.s222114 · Cited by 21
Antioxidants in the treatment of hypertension
Vasdev, S., & Gill, V. D. (2006) · International Journal of Angiology · doi:10.1007/s00547-005-2033-y · Cited by 21
Chen, H., Tang, Y., Ren, P., & Wu, W. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1693441 · Cited by 24
Environmental Toxins and the Heart
Rahnama‐Moghadam, S., Hillis, L. D., & Lange, R. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-416595-3.00003-7 · Cited by 22
Impact of multi-micronutrient supplementation on lipidemia of children and adolescents
Chakrabarti, A., Eiden, M. J., Morin‐Rivron, D., Christinat, N., Monteiro, J. P., Kaput, J., & Masoodi, M. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.09.010 · Cited by 20
Countermeasures for space radiation induced adverse biologic effects
Kennedy, A. R., & Wan, X. S. (2011) · Advances in Space Research · doi:10.1016/j.asr.2011.07.007 · Cited by 21
Dietary Supplements for The Prevention and Treatment of Coronary Artery Disease
Knox, J., & Gaster, B. (2007) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2006.6206 · Cited by 20
“6 This lack of significant effect was also found in other studies, 16,17 one of which found an increase the risk of heart failure with long-term vitamin E supplementation.”
Homji, R. S. M., Lakhoo, S., & Ray, J. G. (2011) · QJM · doi:10.1093/qjmed/hcr027 · Cited by 20
Negi, S., Jeong, E.-M., Shukrullah, I., Veleder, E., Jones, D. P., Fan, T. M., Varadarajan, S., Danilov, S. M., Fukai, T., & Dudley, S. C. (2015) · BioMed Research International · doi:10.1155/2015/825027 · Cited by 20
“This is consistent with a lack of effect of RAS inhibitors and antioxidants in DD [8–12, 30].”
Kobayashi, S. (2006) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.126.677 · Cited by 20
Beneficial Effects of Low-Grade Mitochondrial Stress on Metabolic Diseases and Aging
Min, S. H., Kang, G. M., Park, J.-W., & Kim, M. (2024) · Yonsei Medical Journal · doi:10.3349/ymj.2023.0131 · Cited by 20
“127,128 Mitochondrial oxidative phosphorylation, ATP production, and superoxide production in response to excessive glucose exposure or nutrient stress, decrease in the organs prone to diabetic complications.”
BackgroundVitamin E (α-Tocopherol): Emerging Clinical Role and Adverse Risks of Supplementation in Adults
Kaye, A. D., Thomassen, A. S., Mashaw, S. A., MacDonald, E. M., Waguespack, A., Hickey, L., Singh, A., Gungor, D., Kallurkar, A., Kaye, A. M., et al. (2025) · Cureus · doi:10.7759/cureus.78679 · Cited by 24
Potential Roles of Natural Antioxidants in Modulating Neurodegenerative Disease Pathways
Oyovwi, M. O., Agbonifo‐Chijiokwu, E., Ben‐Azu, B., Atere, A. D., Joseph, G. U., Godsday, O. U., & Udi, O. A. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04874-w · Cited by 21
Fu, Y., Nath, R. G., Dyba, M. D., Cruz, I. M., Pondicherry, S. R., Fernandez, A. I., Schultz, C. L., Yang, P., Pan, J., Desai, D. H., et al. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.04.032 · Cited by 19
Chen, Y., An, N., Zhou, X., Mei, L., Sui, Y., Chen, G., Chen, H., He, S., Jin, C., Hu, Z., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04724-w · Cited by 19
Wang, H., Yang, G., Tian, Y., Li, J., Meng, L., Jiang, X. M., & Xin, Y. (2022) · Aging · doi:10.18632/aging.204247 · Cited by 19
Different Roles of Tocopherols and Tocotrienols in Chemoprevention and Treatment of Prostate Cancer
Jiang, Q. (2024) · Advances in Nutrition · doi:10.1016/j.advnut.2024.100240 · Cited by 20
“Elevation of drug-metabolizing CYP enzymes by α T (at 400 IU) may counteract therapeutic outcomes of medicines in patients and consequently may contribute to increased hospitalization and rates of heart failure among patients taking α T in the HOPE/HOPE-TOO [37].”
BackgroundDuong, T. T. H., Chami, B., McMahon, A. C., Fong, G., Dennis, J. M., Freedman, S. B., & Witting, P. K. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12747 · Cited by 19
“(2014) 130, 733--747 unlikely given the poor outcomes documented for vitamin E in large-scale randomized control studies (Lonn et al. 2005; Sesso et al. 2008).”
Environment-wide association study on childhood obesity in the U.S.
Uche, U. I., Suzuki, S., Fulda, K. G., & Zhou, Z. (2020) · Environmental Research · doi:10.1016/j.envres.2020.110109 · Cited by 21
Preventing Alzheimer’s Disease
Sano, M., Grossman, H. T., & Dyk, K. V. (2008) · CNS Drugs · doi:10.2165/00023210-200822110-00001 · Cited by 19
Cheng, M., Chen, C., Ho, H., Li, J., & Chiu, D. T.-Y. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.09.104 · Cited by 19
(2009) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/j.1541-4337.2009.00081.x · Cited by 19
Zingg, J.-M. A. (2007) · Vitamins and hormones · doi:10.1016/s0083-6729(07)76015-6 · Cited by 19
Statins and cholesterol lowering after a cancer diagnosis: Why not?
Moyad, M. A., & Merrick, G. S. (2005) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2005.03.017 · Cited by 19
Nutritional Management of Maintenance Hemodialysis Patients
Kalantar‐Zadeh, K., & Kopple, J. D. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391934-2.00032-1 · Cited by 19
The Efficacy of Vitamins in the Prevention and Treatment of Cardiovascular Disease
Tappia, P. S., Shah, A. K., & Dhalla, N. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189761 · Cited by 19
“…that vitamin E alone or in combination with other agents was not beneficial and was not associated with all-cause and cardiovascular mortality [202]. of vitamin E did not prevent major cardiovascular The ineffectiveness of vitamin E could be explained on the basis that these study…”
BackgroundIn Situ Conversion of Atherosclerotic Plaques’ Iron into Nanotheranostics
Pan, W., Shao, S., Cao, X., Dai, X., Zheng, Y., Cheng, J., Feng, W., Wu, R., & Chen, Y. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.4c15068 · Cited by 18
Abnormal Ca 2+ Cycling in Failing Ventricular Myocytes: Role of NOS1-Mediated Nitroso-Redox Balance
Ziolo, M. T., & Houser, S. R. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5873 · Cited by 18
“While antioxidant therapy (either scavenging ROS or inhibiting a source of ROS) has beneficial effects in small animal models of HF (4, 76, 117, 128, 147), clinical trials have been disappointing (21, 69, 108, 116).”
Trikalinos, T. A., Moorthy, D., Chung, M., Yu, W. W., Lee, J., Lichtenstein, A. H., & Lau, J. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.07.006 · Cited by 20
LOX-1: A New Target for Therapy for Cardiovascular Diseases
Mehta, J. L., Khaidakov, M., Hermonat, P. L., Mitra, S., Wang, X., Novelli, G., & Sawamura, T. (2011) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-011-6325-5 · Cited by 18
Gliozzi, M., Scarano, F., Musolino, V., Carresi, C., Scicchitano, M., Ruga, S., Zito, M. C., Nucera, S., Bosco, F., Maiuolo, J., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207432 · Cited by 18
Nutritional Considerations in Heart Failure
Payne-Emerson, H., & Lennie, T. A. (2008) · Nursing Clinics of North America · doi:10.1016/j.cnur.2007.10.003 · Cited by 18
Shahidi, F., Zhong, Y., & Chandrasekara, A. (2012) · Wiley eBooks · doi:10.1002/9781118229415.ch19 · Cited by 18
Modulation of Reactive Oxygen Species Homeostasis as a Pleiotropic Effect of Commonly Used Drugs
Thomas, C., Wurzer, L., Malle, E., Ristow, M., & Madreiter‐Sokolowski, C. T. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.905261 · Cited by 18
Progress in Nutritional and Health Profile of Milk and Dairy Products: A Novel Drug Target
Martemucci, G., & D‘Alessandro, A. G. (2013) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/18715303113136660045 · Cited by 17
“However, more research on this molecule is needed, mainly focusing on the long-term use of high-dose vitamin E supplementation, which may increase the risk of developing heart disease [264] and prostate cancer [265].”
BackgroundA review of clinical studies on angiotensin II receptor blockers and risk of cancer
Dézsi, C. A. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.11.031 · Cited by 17
Functional foods in cancer prevention and therapy: Recent epidemiological findings
Islam, S. M. R., & Siddiqua, T. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816151-7.00020-x · Cited by 17
Elrashidy, R. A. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05360-3 · Cited by 17
“Unfortunately, scavenging the ROS by exogenous antioxidants, such as vitamin E or C, has been shown to be of limited therapeutic efficacy against cardiovascular events, including MF [10] and even can increase the risk of heart failure in some clinical trials [11].”
BackgroundAn Objective Appraisal of the Free Radical Theory of Aging
Lustgarten, M. S., Müller, F. L., & Remmen, H. V. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-378638-8.00008-7 · Cited by 18
A cost-effectiveness analysis of n-3 PUFA (Omacor®) treatment in post-MI patients
Quilici, S., Martin, M., McGuire, A. J., & Zöllner, Y. F. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01009.x · Cited by 17
Implications of Oxidative Stress in the Pathophysiological Pathways of Heart Failure
D’Amato, A., Cestiè, C., Ferranti, F., Segato, C., Prosperi, S., Germanò, R., Myftari, V., Bartimoccia, S., Castellani, V., Badagliacca, R., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115165 · Cited by 16
“In fact, the large-scale HOPE trial [72] evaluated long-term supplementation with 400 IU of vitamin E daily in individuals at high cardiovascular risk.”
Makris, K. C., Heibati, B., & Narui, S. Z. (2023) · Environment International · doi:10.1016/j.envint.2023.108048 · Cited by 16
“For example, several double-blind interventional trials in humans showed that a treatment with free-radical-scavenging antioxidants presented with limited evidence for human health benefits (Lonn et al. 2005; Omenn et al. 1996; Williams and Fisher 2005).”
Serbis, A., Pοlyzos, S. A., Paschou, S. Α., Siomou, E. C., & Kiortsis, D. N. (2024) · Endocrine · doi:10.1007/s12020-024-03783-7 · Cited by 16
Chazot, C., Jean, G., & Kopple, J. D. (2015) · Seminars in Dialysis · doi:10.1111/sdi.12443 · Cited by 16
An Evidence-Based Systematic Review of Vitamin A by the Natural Standard Research Collaboration
Ulbricht, C. E., Basch, E., Chao, W., Conquer, J. A., Costa, D., Culwell, S., Flanagan, K. E., Guilford, J., Hammerness, P. G., Hashmi, S., et al. (2012) · Journal of Dietary Supplements · doi:10.3109/19390211.2012.736721 · Cited by 16
“(350) conducted a systematic review and meta-analysis of 12 RCTs (311,134,162,171,188,190,251,261,263,273,285,480,509) to assess the effects of antioxidant supplements on colorectal cancer and/or adenoma prevention (N = 164,460).”
BackgroundČervinková, B., Krčmová, L. K., Solichová, D., Melichar, B., & Solich, P. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-015-9214-0 · Cited by 16
Antioxidants in the Prevention and Treatment of Alzheimer’s Disease
Singh, S. K., Srikrishna, S., Castellani, R. J., & Perry, G. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-67625-8_20 · Cited by 16
Hardon, A. P. (2020) · Critical studies in risk and uncertainty · doi:10.1007/978-3-030-57081-1 · Cited by 23
Moya-Camarena, S. Y., & Jiang, Q. (2011) · Springer eBooks · doi:10.1007/978-94-007-2630-7_15 · Cited by 16
Antwi, S. O., Steck, S. E., Su, L. J., Hébert, J. R., Zhang, H., Fontham, E. T. H., Smith, G. J., Bensen, J. T., Mohler, J. L., & Arab, L. (2015) · The Prostate · doi:10.1002/pros.23025 · Cited by 16
“Two other clinical trials have reported no effect of vitamin E supplementation on CaP incidence [31,32].”
BackgroundReactive Oxygen/Nitrogen Species and the Myocardial Cell Homeostasis: An Ambiguous Relationship
Kuster, G. M., Häuselmann, S. P., Rosc-Schlüter, B. I., Lorenz, V., & Pfister, O. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3464 · Cited by 15
Ultra-Performance Liquid Chromatographic Determination of Tocopherols and Retinol in Human Plasma
Bell, E. C., John, M., Hughes, R. J., & Pham, T. L. (2013) · Journal of Chromatographic Science · doi:10.1093/chromsci/bmt161 · Cited by 16
Vitamins, metabolomics, and prostate cancer
Mondul, A. M., Weinstein, S. J., & Albanes, D. (2016) · World Journal of Urology · doi:10.1007/s00345-016-1878-3 · Cited by 16
“with 400 IU ATA daily [10] and the Physicians’ Health”
BackgroundAntioxidants in Health and Disease
Seifried, R. M., Harrison, E. H., & Seifried, H. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802928-2.00016-3 · Cited by 16
Alpha-Tocopherol Serum Levels Are Increased in Caucasian Women with Uterine Fibroids: A Pilot Study
Ciebiera, M., Szymańska, J., Sentkowska, A., Kilian, K., Rogulski, Z., Nowicka, G., Jakiel, G., Tomaszewski, P., & Włodarczyk, M. (2018) · BioMed Research International · doi:10.1155/2018/6793726 · Cited by 16
Effects of neuromuscular electrical stimulation in patients with heart failure - review.
Ploesteanu, R. L., Nechita, A. C., Turcu, D., Manolescu, B. N., Stamate, S. C., & Berteanu, M. (2018) · Europe PMC (PubMed Central) · Cited by 16
Vitamin E in the Prevention of Prostate Cancer: Where Are We Today?
Lee, I.-M. M., Gaziano, J. M., & Buring, J. E. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj066 · Cited by 16
Werba, J. P., Cavalca, V., Veglia, F., Massironi, P., Franceschi, M. D., Zingaro, L., & Tremoli, E. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.06.020 · Cited by 16
Low in vivo brain glucose consumption and high oxidative stress in accelerated aging
Borrás, C., Stvolinsky, S. L., López-Grueso, R., Федорова, Т. Н., Gambini, J., Болдырев, А. А., & Viña, J. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.06.019 · Cited by 16
Wang, Y., Cao, Z., Gao, Y., Shao, P., Gao, S., Dong, M., Tian, Z., Feng, Y., Xu, J., & Xiang, C. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1661136 · Cited by 16
Vitamin Needs and Treatment for Chronic Kidney Disease Patients
Chazot, C., Steiber, A. L., & Kopple, J. D. (2022) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2022.09.008 · Cited by 15
de Oliveira, V. A., Oliveira, I. K. F., Pereira, I. C., Mendes, L. K. F., da Silva, F. C. C., Torres‐Leal, F. L., Sousa, J. M. D. C. E., & Paiva, A. D. A. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.01.032 · Cited by 17
Jang, Y., & Kim, C. Y. (2024) · Nutrients · doi:10.3390/nu16234115 · Cited by 20
Vitamin E but not St. John’s wort mitigates leukopenia caused by cancer chemotherapy in rats
Branda, R. F., Powden, C., Brooks, E. M., Yildirim, Z., Naud, S. J., & McCormack, J. J. (2006) · Translational research · doi:10.1016/j.trsl.2006.05.007 · Cited by 15
Antioxidants in Health and Disease
Seifried, H. E., & Pilch, S. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391884-0.00018-4 · Cited by 15
Therapeutic potential of nutraceuticals to protect brain after stroke
Chelluboina, B., & Vemuganti, R. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104908 · Cited by 14
Metadata
- Authors
- The HOPE and HOPE-TOO Trial Investigators
- Affiliations
- Population Health Research Institute (CA)
- Corresponding author
- The HOPE and HOPE-TOO Trial Investigators
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2005-03-16
- Volume
- 293
- Issue
- 11
- Pages
- 1338
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1678920698
- Cited by
- 1,209
- References
- 20
- Citations by year
- 2026: 26 · 2025: 26 · 2024: 31 · 2023: 35 · 2022: 35 · 2021: 34 · 2020: 45 · 2019: 37 · 2018: 22 · 2017: 44 · 2016: 48 · 2015: 56 · 2014: 95 · 2013: 70 · 2012: 87
- FWCI
- 58.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council Canada
- Topics
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Keywords
- vitamin E supplementation, long-term supplementation, cancer incidence, cancer mortality, cardiovascular events, myocardial infarction, stroke, cardiovascular mortality, heart failure, unstable angina, revascularization, older adults, vascular disease, diabetes mellitus
- MeSH terms
- Aged, Antioxidants, Cardiovascular Diseases, Diabetes Mellitus, Double-Blind Method, Female, Humans, Male, Middle Aged, Neoplasms, Risk, Vascular Diseases, Dietary Supplements, alpha-Tocopherol
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review